{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:03:04Z","timestamp":1765040584350},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/md.0000000000001334","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T20:02:39Z","timestamp":1439323359000},"page":"e1334","source":"Crossref","is-referenced-by-count":30,"title":["A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease"],"prefix":"10.1097","volume":"94","author":[{"given":"Yi-Chun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Jyh","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Pin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Chu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-39-20210226","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/pgmj.2009.092775","article-title":"Chronic viral hepatitis and chronic kidney disease","volume":"86","author":"Chacko","year":"2010","journal-title":"Postgrad Med J"},{"key":"R2-39-20210226","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(08)60952-6","article-title":"All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan","volume":"371","author":"Wen","year":"2008","journal-title":"Lancet"},{"key":"R3-39-20210226","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ki.2013.455","article-title":"A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease","volume":"85","author":"Chen","year":"2014","journal-title":"Kidney Int"},{"key":"R4-39-20210226","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archinte.167.12.1271","article-title":"Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease","volume":"167","author":"Tsui","year":"2007","journal-title":"Arch Intern Med"},{"key":"R5-39-20210226","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000319456","article-title":"Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis","volume":"32","author":"Noureddine","year":"2010","journal-title":"Am J Nephrol"},{"key":"R6-39-20210226","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/diacare.28.9.2187","article-title":"Hepatitis C is a predictor of poorer renal survival in diabetic patients","volume":"28","author":"Crook","year":"2005","journal-title":"Diabetes Care"},{"key":"R7-39-20210226","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.cgh.2008.03.024","article-title":"Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment","volume":"6","author":"Harrison","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-39-20210226","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000093632","article-title":"Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications","volume":"26","author":"Sarafidis","year":"2006","journal-title":"Am J Nephrol"},{"key":"R9-39-20210226","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2012.04.036","article-title":"Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C","volume":"57","author":"St\u00e4ttermayer","year":"2012","journal-title":"J Hepatol"},{"key":"R10-39-20210226","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","article-title":"Hepatitis C infection and chronic renal diseases","volume":"4","author":"Perico","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-39-20210226","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","article-title":"Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance","volume":"138","author":"Milner","year":"2010","journal-title":"Gastroenterology"},{"key":"R12-39-20210226","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","article-title":"Clinical practice. Chronic hepatitis C infection","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"},{"key":"R13-39-20210226","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2010.11.002","article-title":"Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C","volume":"140","author":"Conjeevaram","year":"2011","journal-title":"Gastroenterology"},{"key":"R14-39-20210226","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/cir076","article-title":"Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more","volume":"52","author":"Pearlman","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R15-39-20210226","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1155\/2003\/710693","article-title":"Oxidative stress in chronic hepatitis C: the effect of interferon therapy and correlation with pathological features","volume":"17","author":"Serejo","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"R16-39-20210226","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/dc11-1511","article-title":"Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications","volume":"35","author":"Sun","year":"2012","journal-title":"Diabetes Care"},{"key":"R17-39-20210226","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.23641","article-title":"Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications","volume":"52","author":"Chen","year":"2010","journal-title":"Hepatology"},{"key":"R18-39-20210226","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ki.2014.363","article-title":"A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan","volume":"87","author":"Chen","year":"2015","journal-title":"Kidney Int"},{"key":"R19-39-20210226","doi-asserted-by":"crossref","first-page":"e36332","DOI":"10.1371\/journal.pone.0036332","article-title":"Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"R20-39-20210226","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/STROKEAHA.109.577742","article-title":"Hyperthyroidism and risk of ischemic stroke in young adults: a 5-year follow-up study","volume":"41","author":"Sheu","year":"2010","journal-title":"Stroke"},{"key":"R21-39-20210226","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/apt.12391","article-title":"Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan","volume":"38","author":"Hsu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-39-20210226","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1746.2009.05789.x","article-title":"Treatment of chronic hepatitis C in Asia: when East meets West","volume":"24","author":"Yu","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R23-39-20210226","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"R24-39-20210226","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7326\/0003-4819-154-9-201105030-00003","article-title":"Comparison of inhaled long-acting beta-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study","volume":"154","author":"Gershon","year":"2011","journal-title":"Ann Intern Med"},{"key":"R25-39-20210226","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2008.10.005","article-title":"United States Renal Data System 2008 Annual Data Report","volume":"53","author":"Collins","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R26-39-20210226","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.26300","article-title":"Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma","volume":"58","author":"Hsu","year":"2013","journal-title":"Hepatology"},{"key":"R27-39-20210226","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection","volume":"308","author":"Wu","year":"2012","journal-title":"JAMA"},{"key":"R28-39-20210226","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ki.2009.431","article-title":"Comorbidity and confounding in end-stage renal disease","volume":"77","author":"Seliger","year":"2010","journal-title":"Kidney Int"},{"key":"R29-39-20210226","first-page":"e8940","article-title":"Propensity score methodology for confounding control in health care utilization databases","volume":"10","author":"Patorno","year":"2013","journal-title":"Epidemiol Biostat Public Health"},{"key":"R30-39-20210226","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.105.594952","article-title":"Propensity scores in cardiovascular research","volume":"115","author":"D\u2019Agostino","year":"2007","journal-title":"Circulation"},{"key":"R31-39-20210226","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"R32-39-20210226","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"key":"R33-39-20210226","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"R34-39-20210226","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1872-034X.2011.00845.x","article-title":"Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy","volume":"41","author":"Arase","year":"2011","journal-title":"Hepatol Res"},{"key":"R35-39-20210226","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12072-011-9284-9","article-title":"Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection","volume":"6","author":"Satapathy","year":"2012","journal-title":"Hepatol Int"},{"key":"R36-39-20210226","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2334-12-86","article-title":"The high comorbidity burden of the hepatitis C virus infected population in the United States","volume":"12","author":"Louie","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R37-39-20210226","first-page":"2051","article-title":"Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa","volume":"9","author":"Liu","year":"2014","journal-title":"Int J Nanomed"},{"key":"R38-39-20210226","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","article-title":"AMPK, insulin resistance, and the metabolic syndrome","volume":"123","author":"Ruderman","year":"2013","journal-title":"J Clin Invest"},{"key":"R39-39-20210226","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"R40-39-20210226","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1681\/ASN.2007121354","article-title":"The secret of immortal time bias in epidemiologic studies","volume":"19","author":"Shariff","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R42-39-20210226","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R43-39-20210226","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/ije\/29.5.891","article-title":"Use of comorbidity scores for control of confounding in studies using administrative databases","volume":"29","author":"Schneeweiss","year":"2000","journal-title":"Int J Epidemiol"},{"key":"R44-39-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.gastro.2014.03.048","article-title":"Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study","volume":"147","author":"Wu","year":"2014","journal-title":"Gastroenterology"},{"key":"R45-39-20210226","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D\u2019Agostino","year":"1998","journal-title":"Stat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:48:17Z","timestamp":1620960497000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201508020-00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":44,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001334","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}